Company News in the Life Science Industry

»

Reset 

Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial

JERUSALEM, July 1, 2020 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) today announced that all participants in the placebo-controlled, blinded, pivotal, clinical efficacy, Phase 3 trial of BiondVax's M-001 universal influenza vaccine candidate have now completed their... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  BiondVax Pharmaceuticals Ltd.

Polygon applies for authorization to convene an extraordinary general meeting of Biotest AG

LONDON, July 1, 2020 /PRNewswire/ -- Polygon Global Partners LLP acts as investment manager to funds and accounts that hold a total of 859,610 ordinary shares and 1,750,000 preferred shares of Biotest AG, representing approximately 6.59% of the share capital of the company.

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  Biotest AG

Invitation to Presentation of BioArctic's Interim Report for the Period January - June 2020 on July 10 at 9.30 a.m. CET

STOCKHOLM, July 1, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company's Interim Report for the period January - June 2020 on Friday, July 1, 2020, at 08:00 a.m. CET.

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  BioArctic AB

RhoVac Marketed in International Press

STOCKHOLM, July 1, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  RhoVac AB

BioInvent Extends Research Collaboration and License Agreement With Pfizer Inc.

LUND, Sweden, July 1, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that it has further extended the research term under its cancer immunotherapy research collaboration and license Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  BioInvent International AB

Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group's Growth Strategy

GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company's new General Manager for Americas. Thanos' appointment will play a critical role in supporting Mentice's continual growth strategy and will help accelerate... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  Mentice AB

Sectra Publishes Annual Report, Sustainability Report and Corporate Governance Report for 2019/2020

LINKÖPING, Sweden, July 1, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  Sectra AB

Clarivate Introduces Next Generation Insights Platform with Cortellis Generics Intelligence

Enhanced Newport platform allows for comprehensive and accurate analysis of market, API and patent data from a single application

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020

UNION Receives Approval From Danish Medicines Agency to Initiate Clinical Study With Niclosamide for Treatment of COVID-19

COPENHAGEN, Denmark, July 1, 2020 /PRNewswire/ -- UNION therapeutics A/S ("UNION"), a privately held clinical stage pharmaceutical company dedicated to the discovery and development of novel medicines for patients with unmet medical needs in inflammatory and infectious diseases, announced this... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  UNION therapeutics A/S

Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB Through License Agreement and Proposes Financing of Subsidiary

STOCKHOLM, Sweden, July 1, 2020 /PRNewswire/ -- Lipidor AB ("Lipidor" or the "Company") and its subsidiary Emollivet AB ("Emollivet") have formalized the relationship by entering into a licence agreement that regulates the right to Lipidor's patented AKVANO® technology.... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

"What if I'm the one?" Bryant Psychologist Heather Lacey leads study on health risk perceptions and behavior

SMITHFIELD, R.I., June 30, 2020 /PRNewswire/ -- A group of researchers, led by Heather Lacey, Ph.D., Professor of Psychology at Bryant University, collaborated to examine how people interpret and respond to risk. The article, Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

KDx Diagnostics Announces CE Marking for Innovative Non-invasive URO17(TM) Bladder Cancer Test

CAMPBELL, Calif., June 30, 2020 /PRNewswire/ -- KDx Diagnostics, Inc., announced today that it has received Conformité Européene (CE) Marking for its innovative and proprietary urine-based test (the URO17(TM) test) for bladder cancer. CE marking establishes that a diagnostic test meets the... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

NuvoAir Reduced Booked and Urgent Face-to-Face Consultations in Cystic Fibrosis Patients

BOSTON, July 1, 2020 /PRNewswire/ -- NuvoAir, a leading digital therapeutics company in respiratory health, is happy to announce the Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System

PALO ALTO, California and SINGAPORE, July 1, 2020 /PRNewswire/ -- Dr. Cipto Mangunkusumo Hospital, Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyon(TM) system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma.

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020
Related companies:  Varian Medical Systems, Inc.

Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework

BAAR, Switzerland, July 1, 2020 /PRNewswire/ -- CARAG AG, a privately-held Swiss medical device development company, today announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for its Carag Bioresorbable Septal Occluder (CBSO). The CE-marked... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

ISA Pharmaceuticals Receives US Orphan-Drug Designation for ISA101b in HPV16-positive Cervical Cancer

Primes the immune system to attack cancer cells in HPV16-positive cancers

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020

vasopharm Announces Last Patient Last Visit in NOSTRA III Traumatic Brain Injury Clinical Trial

Top-line results expected Q4 2020

Read more ››
By: PR Newswire Association LLC. - 01 Jul 2020

Intravacc to In-license CimCure's iBoost Technology, Expanding its Vaccine Platform Portfolio

BILTHOVEN, The Netherlands, July 1, 2020 /PRNewswire/ -- Bilthoven, The Netherlands based Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing... Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

Sickle Cell Anemia Testing & Screening Market Size Worth $340.71 Million by 2027: Grand View Research, Inc.

SAN FRANCISCO, July 1, 2020 /PRNewswire/ -- The global Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020

While Gilead/Galapagos' Filgotinib Will Have to Contend with the Early Success of AbbVie's Rinvoq in the US Rheumatoid Arthritis Market, Eli Lilly's Olumiant is Likely to be the More Formidable Foe in the EU

EXTON, Pa., July 1, 2020 /PRNewswire/ -- Analysis of the most recent semiannual report included in Spherix's Read more ››

By: PR Newswire Association LLC. - 01 Jul 2020
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies